New York – Pfizer reported Tuesday a loss following a sharp fall in the sales of its Covid-19 vaccine and therapeutic from pandemic peaks. The drugmaker reported a third-quarter loss of $2.4 billion, compared with $8.6 billion in profits in the year-ago period. Results were dented by a $5.6 billion…Read More
Pfizer reports loss as Covid19 revenues shrink
